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A B S T R A C T
Purpose: In the United Kingdom all health care providers are encouraged to consult with user groups. The
submissions of charities and patient advocacy groups to NICE and SIGN are considered reﬂective of the
patient groups they purport to represent, yet little is known about how representative they are. This pilot
study was designed to ascertain how many patients attending a hospital based epilepsy clinic were
members of such advocacy groups.
Methods: Patients were asked to complete a brief 9-question questionnaire before they left the clinic.
Results: One hundred and twenty-ﬁve questionnaires were distributed, of which 101 were returned.
Seventeen percent of patients were members of advocacy groups, with several being members of more
than one charity/group. Only seven percent of the respondents had ever been contacted by an advocacy
group to canvass their opinions. Seventy percent of patients questioned stated they thought a frank
discussion with their physician, or specialist nurse was more likely to inﬂuence patient services. Patients
with long duration of disease and taking multiple anti-epileptic drugs were more likely to be members of
charity/advocacy groups.
Conclusions: As patient charities in the UK are often in receipt of public funds, and actively seek to
inﬂuence public policy this raises the question of whether they should be required to consult more
widely with the people they claim to represent.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Health consumer groups (HCG) are a diverse group of voluntary
organisations promoting the interests of patients and carers
through a variety of means. They have proliferated rapidly in the
last 30 years.1 Although often small their impact on the
organisation of health care is increasing, with the UK government
strongly encouraging the National Institute for Clinical Excellence
(NICE) and the Scottish Intercollegiate Guidelines Network (SIGN)
to incorporate the views of patient representatives into their
discussions and recommendations. Both NICE and SIGN issue
guidelines that determine practice in the United Kingdom, and are
inﬂuential around the world. Professional members of these bodies
are recruited because of their qualiﬁcations, experience and
demonstrable expertise in their chosen ﬁeld. Patient representa-
tives who sit on these bodies, however, do not have to provide any* Corresponding author. Tel.: +44 7970904732.
E-mail addresses: Susan.Duncan@ed.ac.uk, susanxduncan@gmail.com
(S. Duncan).
1059-1311/$ – see front matter  2012 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2012.09.016evidence of how representative they are of the generality of
patients suffering from the condition under scrutiny. The authors
are unaware of any systematic examination of how many of our
patients with epilepsy are members of patient representative
groups, or how many of our patients have been consulted by such
groups. Such an examination is timely as SIGN is about to revisit its
guidelines on epilepsy, and NICE published new guidelines for
epilepsy in 2012.
2. Methods
The study was undertaken between March and August 2010 in
the Epilepsy Clinic in the Department of Clinical Neurosciences at
the Western General Hospital Edinburgh. A total of 125
questionnaires were distributed and 101 were returned completed
before the patient left the department. In the case of people with
learning disabilities their carer/support worker was asked to help
them complete the questionnaire.
The questionnaire comprised 7 questions which could be
answered with a tick. The eighth question required the patient to
state an order of preference. A free text box was included at the endvier Ltd. All rights reserved.
Table 1
A B
Self reported employment status Membership of HRG Median years duration of epilepsy (interquartile range) Membership of HRG
59 unemployed 11 members of HRG 12 (10–23) Member (N = 17)
23 full time employed 1
14 part time employed 5 16 (6–22) Not a member (N = 84)
5 students 0
Chisquare P = 0.06 Mann–Whitney P = 0.28
C D
Self reported disability status* Membership of HCG Number of AEDs Membership of HCG
Disabled N = 59 N = 12 No more than 2 N = 64 N = 5
Not disabled N = 30 N = 2 Three or more N = 37 N = 11
Chisquare P = 0.8 Chisquare 0.003
* 12 people did not reply to disability question.
M. Grinton et al. / Seizure 22 (2013) 472–475 473of the questionnaire for comments. The study was sanctioned by
the Lothian Research Ethics Scientiﬁc Ofﬁce.
3. Results
A total of 101 patients completed and returned the question-
naire. Seventeen (17%) were members of an epilepsy charity or
patient self help group dedicated to people with epilepsy. These
were Epilepsy Scotland, Epilepsy Action, The Epilepsy Society, Fife
Epilepsy Network, Epilepsy West Lothian and Scottish Paediatric
Epilepsy Network. Of the 17, 2 were members of three separate
epilepsy associations. Seven of the sixteen (44%) had been
contacted by the group of which they were members to ask for
their opinion on services for people with epilepsy. Some of the
topics included: nocturnal seizures, their opinion on an informa-
tion leaﬂet, and views on medication. Two of the 101 patients had
used services offered by these HCG’s/self help groups. Fifty-nine of
our respondents were unemployed, 23 were in full time
employment, 14 were part time employed and 5 were students.
Employment status did not appear to inﬂuence membership of an
HCG (Table 1A).
There were no signiﬁcant differences in duration of epilepsy
between those who were members of patient groups (Table 1B),
but there was a trend for those who had suffered from the
condition for many years to be members.
Thirty-four (34%) of the respondents took one anti-epileptic
drug (AED) only, 30 (30%) took two AEDs and 37 (37%) took three or
more AEDs. We divided the respondents arbitrarily into those1st Choice for Best Way of Influencing Health Services
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* 18 people did no answer this question.
Graph 1. First choice for best way of inﬂuencing health services. *18 people did not
answer this question.taking no more than two AEDs, and those taking three or more, on
the assumption that the latter group was much more likely to be
intractable. Signiﬁcantly more people who took three or more
AEDs were members of patient advocacy groups than those taking
one or two AEDs (chi-square 0.003) (Table 1D).
There was no signiﬁcant difference in HCG membership
between those who considered themselves disabled as opposed
to those who did not (see Table 1C).
Respondents were asked to rank in order of preference how
they thought they could best inﬂuence services for epilepsy.
Seventy percent replied that a discussion with their general
practitioner (primary care physician), hospital consultant or
epilepsy nurse specialist was their preferred route (see Graph 1).
Four of the 17 people who were members of an epilepsy patient
advocacy group wrote comments in the free text portion of the
questionnaire. One said more information about patient support
and advocacy groups was needed, two wanted more information
about side effects of medication, one wanted information about
mobility scooters.
Of those who were not members of any patient group, one
wanted the population at large educated on how to deal with
seizures, one wanted more support at the time of diagnosis, one
complained about the difﬁculty in getting to see the consultant at
short notice and another wanted to raise his concern about the
stigma associated with epilepsy.
4. Discussion
The present study was limited in terms of patient details. This
reﬂected the need to produce a short questionnaire that would
cause minimal disruption in a busy outpatient clinic. We know
nothing of the 19 people who did not return the questionnaires.
Our aim was to examine the feasibility of doing a larger study with
a more complex questionnaire in outpatients. The most obvious
objection to our method of patient selection is that a specialist
epilepsy clinic is perhaps not especially representative of the
population as a whole. Yet quality of life and other data are
routinely collected from this population.2,3 Conversely in one study
of patients recruited through patient groups the authors speculat-
ed about how representative these patients were.4 In this area of
research no sample group is perfect.
Another potential criticism of our study is that our population
of patient’s needs might not coincide with the stated aims and
intentions of the epilepsy charity/self help groups, who purport to
represent patient interests. In other words there may be another
population of patients elsewhere whose needs are better aligned to
those of various charities. To investigate this further we visited the
charities websites of which our patients were members.
M. Grinton et al. / Seizure 22 (2013) 472–475474The Epilepsy Action website (www.epilepsyaction.org.uk) has a
two page policy statement encompassing everything from aiming
to ensure people with epilepsy have specialist treatment and
health care for their condition, to campaigning to ensure that
within ten years, more people will enjoy good seizure control,
fewer will have died of their epilepsy, fewer people will sustain
harmful side effects from AEDs and there will be greater evidence
of social inclusion for people with epilepsy. All of these aims, with
the exception of the last one are reasons for people being referred
to epilepsy clinics such as the one at the Western General. Epilepsy
Action’s website also offers information on a wide range of topics
and discussion forums for members. It’s members also receive a
regular magazine.
Epilepsy Scotland (www.epilepsyscotland.org.uk) which aims
to be the voice of epilepsy in Scotland, has a one page statement of
aims. The casual reader is left with the impression of a rather
cerebral document, with the overwhelming message that Epilepsy
Scotland is a lobbying and political organisation. It’s website is less
extensive than Epilepsy Action or The Epilepsy Society (www.e-
pilepsysociety.org.uk), but it has information, a helpline and a
menu of it’s activities, including a page for carers and families, and
a clear invitation to join and be involved. Like Epilepsy Action it has
a regular print magazine for its members.
Epilepsy West Lothian (www.epilepsywestlothian.co.uk) has a
modest website which says they are keen to work with people with
epilepsy, their families, carers, colleagues and employers, where
they can be found and their aims in terms of reducing stigma,
improving standards of care, and promoting integrated care.
The Epilepsy Society has an attractive and easily navigable
website. Its stated aim is a full life for everyone affected by
epilepsy. On the website there is easy access to information leaﬂets
and lively discussion forums for the newly diagnosed, carers, and
those who wish to be involved with the society.
The Scottish Paediatric Epilepsy Network (www.spen.scot.nh-
s.uk) – of which one of our patients is a member states it aims to
‘‘promote the delivery of high quality care to children and young
people with the disorder’’. SPEN has developed a patient held
record. Beyond that there is little on the website to encourage lay
participation – if that was ever the intention.
The overwhelming impression given by these organisations
cyber-facades is an enthusiasm to get as many people involved as
possible, to provide as wide a portfolio of services as their funds
allow, and an assumption of literacy on the part of the community
they are striving to serve. Estimates (erring on the generous side) of
the numbers of people in the UK or Scotland with epilepsy are made,
but no breakdown of either membership numbers or the number of
visits the site has received that month are seen. Yet on the evidence
of this small study these organisations do not seem entirely
successful in attracting members. One possible reason for this may
be ignorance on the part of patients, their families and carers of the
work of epilepsy charities. Yet our clinic is festooned with posters
from these charities, we regularly use patient information leaﬂets
from them, and direct patients to their websites.
We did not ask how many of our patients had access to the
Internet and how many used that source to ﬁnd out about their
epilepsy. In retrospect this is probably a signiﬁcant oversight
because informal discussions with ofﬁce bearers of epilepsy
charities reveal large numbers of hits and downloads of their
material.5 This activity, however does not seem to be transformed
into active fee paying membership. That few of our patients appear
to join these associations or use their services is disappointing as
Warsi et al. (2004)6 showed that short self help management
courses run by voluntary groups improve knowledge and coping
behaviour.
We found a trend for those who had suffered the disease
longest to be more likely to be members of HCGs and there was atendency for some people to be members of more than one
group. People taking more than three AEDs were signiﬁcantly
more likely to be members of HCGs, presumably because their
epilepsy was more intractable and they found some of the
pastoral activities of the HCGs they belonged to helpful. We were
surprised that the free text box was not used more. Whether this
reﬂects general contentment with services or widespread apathy
is impossible to tell. It was interesting to observe that patients
felt talking to their consultant or epilepsy nurse was the best way
to improve services, despite these two professional groups often
being painted by politicians and some HCGs as tainted by
‘‘provider interest’’.
A systematic review of user involvement (UI) studies7
suggested in some cases it was little more than tokenism, a way
of validating decisions about health care provision that have
already been made. Other studies allude to difﬁculties between
service users and staff. Some studies report positive outcomes,
many do not measure speciﬁc outcomes. One study of a project to
improve stroke services in two London boroughs invited 500 stroke
survivors to attend meetings to explain the aims of the project.8
Sixty patients attended, which based on the known prevalence of
stroke in those London boroughs this represented 3.3% of stroke
survivors. Those that did attend were not interested in undertaking
administrative or project management roles but wanted to be
involved in writing leaﬂets, and staff training, suggesting people
who got involved want to see something tangible for their efforts.
Equally interesting were the reasons given for getting involved.
Some saw it as a way of learning about the latest stroke research,
others as a way of meeting people like themselves or as a way of
accessing social services.
Another study surveyed UI in mental health services in Greater
London.9 Questionnaires about UI were dispatched to the CEO of all
NHS trusts providing psychiatric services. Questionnaires were
also sent to all UI groups in the locality. The questionnaires were
complimentary and covered the organisation of user groups, and
their relationship to trusts, methods employed to involve users and
outcomes and factors that promoted and impeded UI. In the
questionnaire sent to the user groups the researchers asked what
support they had had from NHS trusts and to rate their overall
satisfaction with the commitment trusts had shown to this type of
working with patients.
Ninety-four (94%) of the mental welfare trusts in the Greater
London area replied to the questionnaire. Of the HCG’s contacted
12% of responses came from groups described as ‘‘no longer
operational’’, 7% from groups not working in NHS mental welfare
services, 48% did return questionnaires. Of these groups the
median number of members was 35 with an average of 10–15
members regularly attending meetings. This study suggested the
HCGs were fragmented and catered to small numbers.
These studies imply UI is the preserve of a small band of
enthusiasts. Reasons for this may be resistance on the part
of professionals to lay involvement, lack of funding, absence of
coherent UI policies on the part of hospital trusts such as providing
childcare or transport for those who express a wish to become
involved. If patient representative groups and charities do not
attract large numbers of active members they may not be able to
put forward enough people to take part in decisions, and again
raises the question of how representative of patients are those
patients who answer the call to become involved.
An example of why some patients might not get involved can be
found on the Scottish Medicines Consortium website. Their
advertisement for lay representatives is 403 words long, requires
a commitment of 3–4 days a month for meetings, up to four hours
long which take place in Glasgow.10
As the power of HCG’s increase an examination of their
inﬂuence on health care providers is timely. A survey by the
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websites showed just 32 listed their donors and only 2 their
funding policy.11 Ball et al. found that although most patient
groups were clear about their aims, only 54% had annual reports
available on the internet, and in less than half of these were
pharmaceutical donations itemised separately from donors in
general. Thus there is a clear potential for conﬂict of interest.12
On the basis of this pilot study, patient representative bodies do
not seem to be very representative. Yet through their websites
these organisations have the capacity to reach many people and
there is no reason why drafts of guidelines and other documents
should not be posted and public comment invited. Equally these
third sector organisations in receipt of public funds could be
required to undertake transparent and inclusive surveys of
the public using their websites, before making any substantive
policy statements.
British medicine is in an era where doctors must submit to
compulsory revalidation to continue practicing. Nurses are expected
to demonstrate clinical competence in all areas of their daily practice
to remain registered and clinical academics must satisfy the rigours
of the research assessment exercise for career progression.
Institutions must prove they have policies and procedures to ensure
patient safety. Yet HCGs do not have to declare their membership
numbers or prove how representative they are. Service user
representation may not be mandatory in the United Kingdom, but
it is increasingly compulsory. This raises issues of legitimacy
especially as many of these organisations are in receipt of public
funds, and in a position to inﬂuence the organisation and delivery of
health care purely by virtue of being HCGs.So how representative are the representatives? And how can
clinicians, who see large numbers of patients every day, help them
to become more representative?
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